Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Netherlands Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20055
20063
20077
20086
20091
20105
20111
20121
20131
20141
20151
20172
20181
20192
20201
20211
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Terminated4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline12
AstraZeneca9
Boehringer Ingelheim7
Novartis Pharmaceuticals4
Pfizer2
Aeris Therapeutics1
Center for Integrated Rehabilitation and Organ Failure Horn1
FLUIDDA nv1
Foresee Pharmaceuticals Co., Ltd.1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive44
Inflammation3
Asthma2
Cachexia2
Amyotrophic Lateral Sclerosis1
Bronchiolitis Obliterans Syndrome1
Bronchitis, Chronic1
Emphysema1
Hypercapnia1
Major Depressive Disorder1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.